Skip to main content
HLB INC. logo

HLB INC. — Investor Relations & Filings

Ticker · 028300 ISIN · KR7028300002 LEI · 988400ZL885PLZG8E576 KO Manufacturing
Open in API
Filings indexed 555 across all filing types
Latest filing 2020-04-14 Proxy Solicitation & In…
Country KR South Korea
Listing KO 028300

About HLB INC.

https://www.hlb.global/

HLB INC. is a biopharmaceutical company focused on developing new global anti-cancer drugs. The company's core activities center on advancing a pipeline of novel therapeutics through its worldwide network, which includes subsidiaries like Elevar Therapeutics and Immunomic Therapeutics. In addition to its primary focus on oncology, HLB's affiliated companies are involved in other life science areas, such as developing and manufacturing in vitro diagnostic medical devices, peptide-based biomaterials, and quasi-drugs. The group also has operations in composite materials and shipbuilding, reflecting its diversified origins.

Recent filings

Filing Released Lang Actions
투자설명서
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a '투자설명서' (Investment Prospectus) issued by HLB Co., Ltd. on April 14, 2020. It contains detailed information regarding a capital increase (rights offering), including offering price, subscription period, payment dates, and extensive risk factors related to the company's business, financial status, and drug development pipeline. In the context of financial filings, a prospectus for a securities offering is classified as a Proxy Solicitation & Information Statement (PSI) or a regulatory filing related to capital raising. Given the specific categories provided, 'PSI' (Proxy Solicitation & Information Statement) is the most appropriate fit for a formal investment prospectus document.
2020-04-14 Korean
[기재정정]증권신고서(지분증권)
Capital/Financing Update Classification · 98% confidence The document is a '증권신고서(지분증권)' (Securities Registration Statement for Equity Securities) filed with the Korean Financial Supervisory Service (DART). It contains detailed information regarding a capital increase (rights offering), use of proceeds, risk factors, and management's discussion of financial conditions. It is a formal regulatory filing required for public offerings of securities. While it contains management's explanations, it is fundamentally a registration statement for a securities offering, which falls under the category of Regulatory Filings (RNS) as it is a formal legal document submitted to the regulator.
2020-04-13 Korean
[기재정정]증권신고서(지분증권)
Capital/Financing Update Classification · 98% confidence The document is a 'Securities Registration Statement' (증권신고서) filed by HLB Co., Ltd. It details a correction (정정신고) to a previously filed registration statement regarding the use of proceeds from a capital increase (유상증자) and related short-term borrowing. This is a formal regulatory filing required by the Financial Supervisory Service (FSS) in South Korea for public offerings. Since it is a formal regulatory document detailing securities issuance and capital changes, it falls under the 'Regulatory Filings' category.
2020-04-10 Korean
단기차입금증가결정
Capital/Financing Update Classification · 98% confidence The document is a formal regulatory disclosure regarding a decision to increase short-term borrowings (단기차입금증가결정). It details the amount, purpose (acquisition of shares in another company), and board approval date. This falls under financing activities and capital structure changes, which aligns with the 'CAP' (Capital/Financing Update) category.
2020-04-08 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official report of the results from an Annual General Meeting (AGM) held on 2020-03-30. It details the outcomes of shareholder votes, including the approval of financial statements, election of directors, and changes to business objectives. This falls directly under the definition of a Declaration of Voting Results & Voting Rights Announcement (DVA).
2020-03-30 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 100% confidence The document is a formal regulatory filing submitted to the Financial Services Commission/Korea Exchange regarding the appointment or resignation of an outside director (사외이사의 선임ㆍ해임 또는 중도퇴임에 관한 신고). This type of disclosure specifically pertains to changes in the company's board of directors, which falls under the 'Board/Management Information' category.
2020-03-30 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.